HEALWELL AI completed the acquisition of BioPharma Services from Think Research for $15m.

HEALWELL AI, a healthcare technology company, completed the acquisition of BioPharma Services, a full-service Contract Research Organization, from Think Research, a clinical content and technology company, for $15m. “This acquisition is not just a joining of forces; it’s a transformation. HEALWELL AI’s various platforms will help expand our clinical trial capabilities. The acquisition allows us to leverage HEALWELL’s data science expertise to further improve our service offerings. The integration of AI in our processes such as trial design, feasibility and risk assessment, patient eligibility stratification, and results analysis will significantly enhance our capabilities. By expanding our reach to patient trials, including rare disease trials, BioPharma Services will enhance the medical journey for patients, families, and communities,” Anna Taylor, BioPharma Managing Director.